The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: Findings from the 4C-MCI study

Psychological Medicine

Volumn 45, Issue 7, 2015, Pages 1509-1519

  Hamel, R ^a   Kohler S ^a   Sistermans, N ^a   Koene, T ^b   Pijnenburg, Y ^b   Van Der Flier, W ^b   Scheltens, P ^b   Aalten, P ^b   Verhey, F ^c   Visser, P J ^a   Ramakers, I ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; cognition; cohort study; neuropsychology

Indexed keywords

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE COURSE; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; PSYCHOMOTOR PERFORMANCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY, EPISODIC; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NETHERLANDS; PRODROMAL SYMPTOMS; PSYCHOMOTOR PERFORMANCE;

EID: 84925847920     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714002645     Document Type: Article

References (56)

1. Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ (2007). Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology 21, 158-169
2. Albert MS, Moss MB, Tanzi R, Jones K (2001). Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society 7, 631-639
3. Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, Barberger-Gateau P, Fabrigoule C, Dartigues JF (2005). The 9 year cognitive Decline before Dementia of the Alzheimer type: a prospective population-based study. Brain 128, 1093-1101
4. APA (1994). Diagnostic and Statistical Manual of Mental DisorDers, 4th edn. American Psychiatric Association: Washington, DC
5. Auriacombe S, Fabrigoule C, Lafont S, Jacqmin-Gadda H, Dartigues JF (2001). Letter and cateogry fluency in normal elDerly participants: a population-based study. Aging, Neuropsychology and Cognition 8, 98-108
6. Backman L, Small BJ (1998). Influences of cognitive support on episodic remembering: tracing the process of loss from normal aging to Alzheimers disease. Psychology and Aging 13, 267-276
7. Backman L, Small BJ, Fratiglioni L (2001). Stability of the preclinical episodic memory Deficit in Alzheimers disease. Brain 124, 96-102
8. Bunce D, Batterham PJ, Mackinnon AJ, Christensen H (2012). Depression, anxiety and cognition in community-dwelling adults aged 70 years and over. Journal of Psychiatric Research 46, 1662-1666
9. Burgmans S, Van Boxtel MP, Smeets F, Vuurman EF, Gronenschild EH, Verhey FR, Uylings HB, Jolles J (2009). Prefrontal cortex atrophy predicts Dementia over a six-year period. Neurobiology of Aging 30, 1413-1419
10. Cerhan JH, Ivnik RJ, Smith GE, Machulda MM, Boeve BF, Knopman DS, Petersen RC, Tangalos EG (2007). Alzheimers disease patients cognitive status and course years prior to symptom recognition. Aging, Neuropsychology, and Cognition 14, 227-235
11. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M (2000). Cognitive tests that best discriminate between presymptomatic AD and those who remain nonDemented. Neurology 55, 1847-1853
12. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M (2001). Patterns of cognitive Decline in presymptomatic Alzheimer disease: a prospective community study. Archives of General Psychiatry 58, 853-858
13. Clark LJ, Gatz M, Zheng L, Chen YL, McCleary C, Mack WJ (2009). Longitudinal verbal fluency in normal aging, preclinical, and prevalent Alzheimers disease. American Journal of Alzheimers Disease and Other Dementias 24, 461-468
14. Crossley M, DArcy C, Rawson NS (1997). Letter and category fluency in community-dwelling Canadian seniors: a comparison of normal participants to those with Dementia of the Alzheimer or vascular type. Journal of Clinical and Experimental Neuropsychology 19, 52-62
15. Fabrigoule C, Rouch I, Taberly A, Letenneur L, Commenges D, Mazaux JM, Orgogozo JM, Dartigues JF (1998). Cognitive process in preclinical phase of Dementia. Brain 121(Pt 1), 135-141
16. Ferrer E, Salthouse TA, Stewart WF, Schwartz BS (2004). MoDeling age and retest processes in longitudinal studies of cognitive abilities. Psychology and Aging 19, 243-259
17. Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN (1998). Presymptomatic cognitive Deficits in individuals at risk of familial Alzheimers disease. A longitudinal prospective study. Brain 121(Pt 9), 1631-1639
18. Galvin JE, Powlishta KK, Wilkins K, McKeel DW Jr., Xiong C, Grant E, Storandt M, Morris JC (2005). Predictors of preclinical Alzheimer disease and Dementia: a clinicopathologic study. Archives of Neurology 62, 758-765
19. Grober E, Hall CB, Lipton RB, ZonDerman AB, Resnick SM, Kawas C (2008). Memory impairment, executive dysfunction, and intellectual Decline in preclinical Alzheimers disease. Journal of the International Neuropsychological Society 14, 266-278
20. Hammes J (1973). De Stroop Kleur-Woord Test: Handleiding [The Stroop Color-Word Test: Manual]. Swets &Zeitlinger: Amsterdam
21. Hanninen T, Hallikainen M, Koivisto K, Helkala EL, Reinikainen KJ, Soininen H, Mykkanen L, Laakso M, Pyorala K, Riekkinen PJ Sr. (1995). A follow-up study of age-Associated memory impairment: neuropsychological predictors of Dementia. Journal of the American Geriatrics Society 43, 1007-1015
22. Jack Jr. CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010). Hypothetical moDel of dynamic biomarkers of the Alzheimers pathological cascaDe. LancetNeurology 9, 119-128
23. Jacobs HI, Van Boxtel MP, Uylings HB, Gronenschild EH, Verhey FR, Jolles J (2011). Atrophy of the parietal lobe in preclinical Dementia. Brain and Cognition 75, 154-163
24. Johnson DK, Storandt M, Morris JC, Galvin JE (2009). Longitudinal study of the transition from healthy aging to Alzheimer disease. Archives of Neurology 66, 1254-1259
25. Laukka EJ, Jones S, Small BJ, Fratiglioni L, Backman L (2004). Similar patterns of cognitive Deficits in the preclinical phases of vascular Dementia and Alzheimers disease. Journal of the International Neuropsychological Society 10, 382-391
26. Laukka EJ, Macdonald SW, Fratiglioni L, Backman L (2012). Preclinical cognitive trajectories differ for Alzheimers disease and vascular Dementia. Journal of the International Neuropsychological Society 18, 191-199
27. Lezak MD, Howieson DB, Loring DW (2004). Neuropsychological Assessment, 4th edn. Oxford University Press: Oxford, UK
28. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, Kaplan EF, DAgostino RB (1995). The preclinical phase of probable Alzheimers disease. A 13-year prospective study of the Framingham cohort. Archives of Neurology 52, 485-490
29. Luteijn F, Barelds DPH (2004). Groninger Intelligentie Test 2 Handleiding [Groninger Intelligence Test 2 Manual]. Harcourt Assessment BV: Amsterdam
30. Machulda MM, Pankratz VS, Christianson TJ, Ivnik RJ, Mielke MM, Roberts RO, Knopman DS, Boeve BF, Petersen RC (2013). Practice effects and longitudinal cognitive change in normal aging vs. inciDent mild cognitive impairment and Dementia in theMayo Clinic Study of Aging. The Clinical Neuropsychologist 27, 1247-1264
31. McKeith IG, Dickson DW, Lowe J, Emre M, OBrien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, LitVan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005). Diagnosis and management of Dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863-1872
32. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDAWork Group unDer the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 34, 939-944
33. Mitchell AJ, Shiri-Feshki M (2009). Rate of progression of mild cognitive impairment to Dementia-meta-Analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica 119, 252-265
34. Mitrushina M, Satz P (1991). Effect of repeated administration of a neuropsychological battery in the elDerly. Journal of Clinical Psychology 47, 790-801
35. Mungas D, Beckett L, Harvey D, Farias ST, Reed B, Carmichael O, Olichney J, Miller J, DeCarli C (2010). Heterogeneity of cognitive trajectories in diverse olDer persons. Psychology and Aging 25, 606-619
36. Neary D, SnowDen JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998). Frontotemporal lobar Degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546-1554
37. Nielsen H, Lolk A, AnDersen K, AnDersen J, Kragh-Sorensen P (1999). Characteristics of elDerly who Develop Alzheimers disease during the next two years-A neuropsychological study using CAMCOG. The ODense Study. International Journal of Geriatric Psychiatry 14, 957-963
38. OBrien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST (2003). Vascular cognitive impairment. Lancet Neurology 2, 89-98
39. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 56, 303-308
40. Raoux N, Amieva H, Le Goff M, Auriacombe S, Carcaillon L, Letenneur L, Dartigues JF (2008). Clustering and switching processes in semantic verbal fluency in the course of Alzheimers disease subjects: results from the PAQUID longitudinal study. Cortex 44, 1188-1196
41. Rapp MA, Reischies FM (2005). Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). American Journal of Geriatric Psychiatry 13, 134-141
42. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006). Tracking atrophy progression in familial Alzheimers disease: a serial MRI study. Lancet Neurology 5, 828-834
43. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, MasDeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, OBrien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993). Vascular Dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260
44. Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L (1998). A prospective study of cognitive function and onset of Dementia in cognitively healthy elDers. Archives of Neurology 55, 395-401
45. Schmand B, Houx P, De Koning I (2003). Normen voor Stroop kleur-woord tests, Trail Making test en Story Recall Van De Rivermead Behavioural Memory Test. [Norms for Stroop color-word tests, Trail Making Test and Story Recall of the Rivermead Behavioural Memory Test]. NeDerlands Instituut Van Psychologen, Sectie Neuropsychologie: Amsterdam
46. Silva D, Guerreiro M, Santana I, Rodrigues A, Cardoso S, Maroco J, De Mendonca A (2013). Prediction of long-term (5 years) conversion to Dementia using neuropsychological tests in a memory clinic setting. Journal of Alzheimers Disease 34, 681-689
47. Sluimer JD, Van Der Flier WM, Karas GB, Van SchijnDel R, Barnes J, Boyes RG, Cover KS, Olabarriaga SD, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009). Accelerating regional atrophy rates in the progression from normal aging to Alzheimers disease. European Radiology 19, 2826-2833
48. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, DeVanand DP (2006). Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Archives of General Psychiatry 63, 916-924
49. Thorvaldsson V, Macdonald SW, Fratiglioni L, Winblad B, Kivipelto M, Laukka EJ, Skoog I, Sacuiu S, Guo X, Ostling S, Borjesson-Hanson A, Gustafson D, Johansson B, Backman L (2011). Onset and rate of cognitive change before Dementia diagnosis: findings from two Swedish population-based longitudinal studies. Journal of the International Neuropsychological Society 17, 154-162
50. Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J (2005). Reys verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and moDe of presentation. Journal of the International Neuropsychological Society 11, 290-302
51. Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J (2006a). Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. Journal of the International Neuropsychological Society 12, 80-89
52. Van Der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J (2006b). The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 13, 62-79
53. Van Der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, Van Berckel BN, Stam CJ, Barkhof F, Visser PJ, Van Egmond E, Scheltens P (2014). Optimizing patient care and research: the amsterdam Dementia cohort. Journal of Alzheimers Disease 41, 313-327
54. Van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, Van Der Flier WM (2013). Preclinical AD predicts Decline in memory and executive functions in subjective complaints. Neurology 81, 1409-1416
55. Wilson RS, Beckett LA, Bennett DA, Albert MS, EVans DA (1999). Change in cognitive function in olDer persons from a community population: relation to age and Alzheimer disease. Archives of Neurology 56, 1274-1279
56. Wilson RS, Leurgans SE, Boyle PA, Bennett DA (2011). Cognitive Decline in prodromal Alzheimer disease and mild cognitive impairment. Archives of Neurology 68, 351-356